Skip to main content
. 2022 Jun 23;13:893679. doi: 10.3389/fendo.2022.893679

Table 2.

Embryo transfer and live birth outcomes.

Variable NOA couples
1st embryo transfer cycle
 No. of embryos transferred 1.55 ± 0.50
 Clinical pregnancy rate (%) 45.48 (136/299)
 Live birth rate (%) 43.49 (130/299)
Cumulative Pregnancy
 No. of patients with clinical pregnancy/undergoing ICSI cycles with available embryos (%) 56.82 (150/264)
 No. of patients with clinical pregnancy/undergoing ICSI cycles (%) 50.17 (150/299)
 No. of patients with clinical pregnancy/successful sperm retrieval (%) 34.72 (150/432)
Cumulative Live birth
 No. live birth/clinical pregnancy (%) 93.33 (140/150)
  Singleton (%) 87.14 (122/140)
  Twins (%) 12.86 (18/140)
 No. live birth/undergoing ICSI cycles with available embryos (%) 53.03 (140/264)
 No. live birth/undergoing ICSI cycles (%) 46.82 (140/299)
 No. live birth/successful sperm retrieval (%) 32.41 (140/432)
 No. premature infants/live birth (%) 18.57 (26/140)
 No. cesarean delivery/live birth (%) 31.43 (44/140)
 No. birth defects/live birth (%)# 1.43 (2/140)
Gender
  Male (%) 39.24 (62/158)
  Female (%) 60.76 (96/158)
Birth weight (g) 2981.27 ± 534.65
  Singleton (n =122) 3174.18 ± 419.13
  Twins (n =18, 36 babies) 2327.50 ± 324.95
Height (cm) 48.65 ± 3.13
  Singleton (n =122) 49.66 ± 2.23
  Twins (n =18, 36 babies) 45.19 ± 3.32

Data are expressed as mean ± SD unless indicated otherwise.

#One case is a cardiovascular malformation, and the other is a cleft lip and palate.

ICSI, intracytoplasmic sperm injection; NOA, non-obstructive azoospermia.